A functional network module for Smith-Magenis syndrome

Santhosh Girirajan, H. T. Truong, C. L. Blanchard, Sarah H. Elsea

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Disorders with overlapping diagnostic features are grouped into a network module. Based on phenotypic similarities or differential diagnoses, it is possible to identify functional pathways leading to individual features. We generated a Smith-Magenis syndrome (SMS)-specific network module utilizing patient clinical data, text mining from the Online Mendelian Inheritance in Man database, and in vitro functional analysis. We tested our module by functional studies based on a hypothesis that RAI1 acts through phenotype-specific pathways involving several downstream genes, which are altered due to RAI1 haploinsufficiency. A preliminary genome-wide gene expression study was performed using microarrays on RAI1 haploinsufficient cells created by RNAi-based ∼50% knockdown of RAI1 in HEK293T cells. The top dysregulated genes were involved in growth signaling and insulin sensitivity, neuronal differentiation, lipid biosynthesis and fat mobilization, circadian activity, behavior, renal, cardiovascular and skeletal development, gene expression, and cell-cycle regulation and recombination, reflecting the spectrum of clinical features observed in SMS. Validation using real-time quantitative reverse transcriptase polymerase chain reaction confirmed the gene expression profile of 75% of the selected genes analyzed in both HEK293T RAI1 knockdown cells and SMS lymphoblastoid cell lines. Overall, these data support a method for identifying genes and pathways responsible for individual clinical features in a complex disorder such as SMS.

Original languageEnglish (US)
Pages (from-to)364-374
Number of pages11
JournalClinical Genetics
Volume75
Issue number4
DOIs
StatePublished - Apr 27 2009

Fingerprint

Smith-Magenis Syndrome
Data Mining
Genes
Genetic Databases
Gene Expression
Haploinsufficiency
RNA Interference
Reverse Transcriptase Polymerase Chain Reaction
Transcriptome
Genetic Recombination
Insulin Resistance
Cell Cycle
Differential Diagnosis
Fats
Genome
Databases
Phenotype
Kidney
Lipids
Cell Line

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Girirajan, Santhosh ; Truong, H. T. ; Blanchard, C. L. ; Elsea, Sarah H. / A functional network module for Smith-Magenis syndrome. In: Clinical Genetics. 2009 ; Vol. 75, No. 4. pp. 364-374.
@article{8b5a16b93c45407d9e8e35d506017b77,
title = "A functional network module for Smith-Magenis syndrome",
abstract = "Disorders with overlapping diagnostic features are grouped into a network module. Based on phenotypic similarities or differential diagnoses, it is possible to identify functional pathways leading to individual features. We generated a Smith-Magenis syndrome (SMS)-specific network module utilizing patient clinical data, text mining from the Online Mendelian Inheritance in Man database, and in vitro functional analysis. We tested our module by functional studies based on a hypothesis that RAI1 acts through phenotype-specific pathways involving several downstream genes, which are altered due to RAI1 haploinsufficiency. A preliminary genome-wide gene expression study was performed using microarrays on RAI1 haploinsufficient cells created by RNAi-based ∼50{\%} knockdown of RAI1 in HEK293T cells. The top dysregulated genes were involved in growth signaling and insulin sensitivity, neuronal differentiation, lipid biosynthesis and fat mobilization, circadian activity, behavior, renal, cardiovascular and skeletal development, gene expression, and cell-cycle regulation and recombination, reflecting the spectrum of clinical features observed in SMS. Validation using real-time quantitative reverse transcriptase polymerase chain reaction confirmed the gene expression profile of 75{\%} of the selected genes analyzed in both HEK293T RAI1 knockdown cells and SMS lymphoblastoid cell lines. Overall, these data support a method for identifying genes and pathways responsible for individual clinical features in a complex disorder such as SMS.",
author = "Santhosh Girirajan and Truong, {H. T.} and Blanchard, {C. L.} and Elsea, {Sarah H.}",
year = "2009",
month = "4",
day = "27",
doi = "10.1111/j.1399-0004.2008.01135.x",
language = "English (US)",
volume = "75",
pages = "364--374",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "4",

}

A functional network module for Smith-Magenis syndrome. / Girirajan, Santhosh; Truong, H. T.; Blanchard, C. L.; Elsea, Sarah H.

In: Clinical Genetics, Vol. 75, No. 4, 27.04.2009, p. 364-374.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A functional network module for Smith-Magenis syndrome

AU - Girirajan, Santhosh

AU - Truong, H. T.

AU - Blanchard, C. L.

AU - Elsea, Sarah H.

PY - 2009/4/27

Y1 - 2009/4/27

N2 - Disorders with overlapping diagnostic features are grouped into a network module. Based on phenotypic similarities or differential diagnoses, it is possible to identify functional pathways leading to individual features. We generated a Smith-Magenis syndrome (SMS)-specific network module utilizing patient clinical data, text mining from the Online Mendelian Inheritance in Man database, and in vitro functional analysis. We tested our module by functional studies based on a hypothesis that RAI1 acts through phenotype-specific pathways involving several downstream genes, which are altered due to RAI1 haploinsufficiency. A preliminary genome-wide gene expression study was performed using microarrays on RAI1 haploinsufficient cells created by RNAi-based ∼50% knockdown of RAI1 in HEK293T cells. The top dysregulated genes were involved in growth signaling and insulin sensitivity, neuronal differentiation, lipid biosynthesis and fat mobilization, circadian activity, behavior, renal, cardiovascular and skeletal development, gene expression, and cell-cycle regulation and recombination, reflecting the spectrum of clinical features observed in SMS. Validation using real-time quantitative reverse transcriptase polymerase chain reaction confirmed the gene expression profile of 75% of the selected genes analyzed in both HEK293T RAI1 knockdown cells and SMS lymphoblastoid cell lines. Overall, these data support a method for identifying genes and pathways responsible for individual clinical features in a complex disorder such as SMS.

AB - Disorders with overlapping diagnostic features are grouped into a network module. Based on phenotypic similarities or differential diagnoses, it is possible to identify functional pathways leading to individual features. We generated a Smith-Magenis syndrome (SMS)-specific network module utilizing patient clinical data, text mining from the Online Mendelian Inheritance in Man database, and in vitro functional analysis. We tested our module by functional studies based on a hypothesis that RAI1 acts through phenotype-specific pathways involving several downstream genes, which are altered due to RAI1 haploinsufficiency. A preliminary genome-wide gene expression study was performed using microarrays on RAI1 haploinsufficient cells created by RNAi-based ∼50% knockdown of RAI1 in HEK293T cells. The top dysregulated genes were involved in growth signaling and insulin sensitivity, neuronal differentiation, lipid biosynthesis and fat mobilization, circadian activity, behavior, renal, cardiovascular and skeletal development, gene expression, and cell-cycle regulation and recombination, reflecting the spectrum of clinical features observed in SMS. Validation using real-time quantitative reverse transcriptase polymerase chain reaction confirmed the gene expression profile of 75% of the selected genes analyzed in both HEK293T RAI1 knockdown cells and SMS lymphoblastoid cell lines. Overall, these data support a method for identifying genes and pathways responsible for individual clinical features in a complex disorder such as SMS.

UR - http://www.scopus.com/inward/record.url?scp=64949182814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64949182814&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0004.2008.01135.x

DO - 10.1111/j.1399-0004.2008.01135.x

M3 - Article

C2 - 19236431

AN - SCOPUS:64949182814

VL - 75

SP - 364

EP - 374

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 4

ER -